Table 2.

Table 2a. Associations between subject characteristics (categorical) and preference for treatment associated with severe side effects
Characteristic		Percent Preferring Treatment (N)	P value
Race	White	50 (41)	0.7
	Other	53 (31)
Gender	Male	48 (57)	0.05
	Female	71 (15)
Marital status	Married	39 (13)	0.1
	Not married	55 (59)
Education	Some college	49 (31)	0.6
	No college	53 (41)
Employment status	Employed	43 (23)	0.1
	Unemployed	57 (49)
Site	Veteran	47 (45)	0.1
	Nonveteran	61 (27)
Health status	Excellent/very good	40 (12)	0.2
	Good/fair/poor	55 (60)
Mental illness	No	48 (41)	0.4
	Yes	55 (30)
Degree of fibrosis	Mild/none	29 (17)	0.0001
	Moderate	61 (41)
	Severe	93 (14)
Genotype	1	49 (54)	0.03
	2	74 (17)
Alcohol use	Never	58 (29)	0.2
	Ever	48 (43)
Drug abuse	Never	53 (10)	0.9
	Ever	51 (62)

Table 2b. Associations between subject characteristics (continuous) and preference for treatment associated with severe side effects.
Median (range)
Characteristic	Subjects preferring treatment (N=72)	Subjects not preferring treatment (N=68)	P value
Age	52 (23–64)	53 (26–70)	0.1
HCV-related quality of life	28 (0–77)	14 (0–84)	0.03
Expectation of developing cirrhosis	50 (0–100)	33 (0–100)	<0.0004
Social support	62 (5–100)	63 (12–100)	0.7
Trust in physician	57 (36–68)	55 (34–68)	0.2
Decisional conflict	25 (0–58)	34 (0–73)	0.02